Parkinson's drug may change gum disease risk, study finds
NCT ID NCT07405268
First seen Feb 13, 2026 · Last updated May 14, 2026 · Updated 19 times
Summary
This study looks at how the Parkinson's drug Levodopa-Benserazide affects gum health and certain substances in saliva. Researchers compared four groups of people: those with and without Parkinson's, and those with and without gum disease. The goal is to understand if the medication influences gum inflammation and overall oral health.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PERIODONTAL DISEASES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Sağlık Bilimleri Üniversitesi Gülhane Diş Hekimliği Fakültesi
Ankara, 06010, Turkey (Türkiye)
Conditions
Explore the condition pages connected to this study.